Cybin (CYBN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CYBN Cybin

Watchlist

11.3199
+0.1599+1.43%

Trading Nov 21 09:31 ET

226.31MMarket Cap-1850P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
Moomoo NewsNov 19 07:33 ET · Ratings
Optimistic Buy Rating for Cybin: Promising CYB003 Phase 2 Results and Market Potential
TipRanksNov 19 06:56 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target
BenzingaNov 18 12:13 ET
Sector Update: Health Care Stocks Mixed Premarket Monday
MT NewswiresNov 18 09:19 ET
Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year
MT NewswiresNov 18 08:09 ET
Express News | Cybin Inc - Initiates Phase 3 Paradigm Program for Cyb003
ReutersNov 18 07:01 ET

Comments

EZ_money

Nov 19 07:44

$Cybin (CYBN.US)$👀 more news out on trials 100% effectiveness so far on the therapy drug for treating depression
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
trading under 12 now seems like something is in the works.
$Vertex Pharmaceuticals (VRTX.US)$ $Astera Labs (ALAB.US)$ $Emergent BioSolutions (EBS.US)$

EZ_money

Nov 18 14:05

$Cybin (CYBN.US)$ break the downward wedge LFG 🐂💥🚀

EZ_money

Nov 18 11:50

$Cybin (CYBN.US)$ say what ??? 🤣
$NVIDIA (NVDA.US)$ $Tesla (TSLA.US)$ $SoFi Technologies (SOFI.US)$

EZ_money

Nov 18 11:48

$Cybin (CYBN.US)$ i suppose the good news is reason to sell

Jaguar8

Nov 18 08:19

NEWS

$Cybin (CYBN.US)$
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
Cybin Inc. (NYSE American:CYBN)reported groundbreaking 12-month efficacy data from its Phase 2 study of CYB003 for major depressive disorder (MDD). After two 16mg doses administered three weeks apart, 100% of participants were responsive to treatment, with 71% in remission at 12 months. The study showed a ~23-point reduction in MADRS depression s...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CYBN Cybin

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target